Detalhe da pesquisa
1.
Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti-PD-1-Based Immunotherapy as Curative-Intent Treatment.
J Natl Compr Canc Netw
; 22(3)2024 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498975
2.
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial.
Ann Surg
; 277(4): 557-564, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538627
3.
Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair-Deficient Colorectal Cancer.
J Natl Compr Canc Netw
; 21(1): 60-66.e5, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630898
4.
Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Dis Colon Rectum
; 66(10): e996-e1005, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485833
5.
Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel.
J Med Genet
; 59(4): 370-376, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563768
6.
Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features.
Int J Cancer
; 144(9): 2161-2168, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30521064
7.
Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.
J Surg Oncol
; 109(5): 478-82, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24288203
8.
Is early surveillance with CT scan necessary in patients with stage II/III colorectal cancer: a retrospective study.
J Surg Oncol
; 108(8): 568-71, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105780
9.
Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients.
Eur J Cancer
; 192: 113253, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625240
10.
Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study.
Eur J Cancer
; 174: 176-184, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030556
11.
PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer.
Oncoimmunology
; 9(1): 1711650, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32042474
12.
The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Oncotarget
; 6(32): 33919-25, 2015 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26416245
13.
The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Medicine (Baltimore)
; 94(47): e2074, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26632714
14.
Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial.
Int J Radiat Oncol Biol Phys
; 90(5): 1153-60, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25442042